CD31 with strong membrane-based immunoreactivity in ductal carcinoma of the breast

Applied Immunohistochemistry and Molecular Morphology

Volumn 8, Issue 4, 2000, Pages 334-335

  Ortiz Hidalgo, C ^a   Torres, J E ^a   Cuesta Mejias, T ^a   Mendoza Ramon, H ^a  

^a AMERICAN BRITISH COWDRAY MEDICAL CENTER   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN;

ADENOSQUAMOUS CARCINOMA; ANTIGEN EXPRESSION; BREAST CARCINOMA; BREAST DUCT; CELL DIFFERENTIATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LETTER; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

ANTIGENS, CD31; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIAGNOSIS, DIFFERENTIAL; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0033693616     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200012000-00012     Document Type: Letter

References (4)

1. CD31 immunoreactivity in small round cell tumor
2. CD31 immunoreactivity in carcinomas and mesotheliomas
3. Endothelial markers CD31, CD34 and BNH9 antibody to H and Y-antigens- Evaluation of their specificity and sensitivity in the diagnosis of vacular tumors and comparison with von Willebrand factor
4. Molecular cloning of CD31, a putative intercellular adhesion molecule close related to carcinoembrionic antigen